1. Home
  2. CRNC vs VALN Comparison

CRNC vs VALN Comparison

Compare CRNC & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cerence Inc.

CRNC

Cerence Inc.

HOLD

Current Price

$8.45

Market Cap

479.9M

Sector

Technology

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.85

Market Cap

495.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNC
VALN
Founded
2020
2012
Country
United States
France
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.9M
495.5M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
CRNC
VALN
Price
$8.45
$6.85
Analyst Decision
Hold
Strong Buy
Analyst Count
4
2
Target Price
$10.25
$15.50
AVG Volume (30 Days)
700.2K
78.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
96.95
N/A
EPS
N/A
N/A
Revenue
$251,781,000.00
N/A
Revenue This Year
$27.18
N/A
Revenue Next Year
N/A
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.85
$4.75
52 Week High
$13.74
$12.23

Technical Indicators

Market Signals
Indicator
CRNC
VALN
Relative Strength Index (RSI) 49.28 66.26
Support Level $7.72 $5.03
Resistance Level $9.39 $7.31
Average True Range (ATR) 0.40 0.23
MACD 0.08 -0.03
Stochastic Oscillator 67.53 59.80

Price Performance

Historical Comparison
CRNC
VALN

About CRNC Cerence Inc.

Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: